Stonnington Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$672K Sell
10,025
-2,725
-21% -$175K 0.17% 121
2022
Q4
$766K Buy
+12,750
New +$521K 0.21% 104
2021
Q3
Sell
-1,730
Closed -$202K 271
2021
Q2
$202K Buy
+1,730
New +$206K 0.04% 266

Other funds holding EXAS

Stonnington Group's EXAS Position: Q1 2023 in Review

Stonnington Group reduced its Exact Sciences (EXAS) stake by 21% in Q1 2023, selling an estimated $175K and leaving 10,025 shares worth $672K. The position accounts for 0.17% of the portfolio, ranked #121.

Stonnington Group first reported a position in EXAS in Q2 2021 and has held it in 3 quarters since. The position peaked at $766K in Q4 2022. 582 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • Stonnington Group held 10,025 shares of Exact Sciences worth $672K as of Q1 2023.
  • Stonnington Group sold 2,725 Exact Sciences shares in Q1 2023, an estimated $175K.
  • Exact Sciences made up 0.17% of Stonnington Group's portfolio in Q1 2023, its #121 holding.
  • Stonnington Group first reported a position in Exact Sciences in Q2 2021 and has held it in 3 quarters since.
  • Stonnington Group's Exact Sciences position peaked at $766K in Q4 2022.
  • 582 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on Stonnington Group's 13F filing for Q1 2023, filed 14 Apr 2023.